Form 483

KYMOS S.L. Form 483, 2017-07-18

FDA issued a Form 483 to KYMOS S.L. on 2017-07-18 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

KYMOS S.L. · Cerdanyola Del Valles, Spain · Issued July 18, 2017

Overview

  • 8 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Jul 2017
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Toyin B Oladimeji

18 Jul 2017
21 CFR 211.160(a)

Deviations from laboratory control requirements

Cited by Toyin B Oladimeji

18 Jul 2017
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Toyin B Oladimeji

18 Jul 2017
21 CFR 211.165(a)

Testing and release for distribution

Cited by Toyin B Oladimeji

18 Jul 2017
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Toyin B Oladimeji

Inspected site

KSKYMOS S.L.Cerdanyola Del Valles, Spain

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere